|
|
|
Health - Does Chocolate Cause Acne
Does Chocolate Cause Acne
Acne is the most common skin disorder in America. Millions of
people suffer from Acne each year. Many people are unsure of
what causes acne and how to treat it. Here is some information
that may make acne easier to...
Prevention Is Time-Tested Prescription For Acne
The American Academy of Dermatology has revealed that taking pains to have a clear, blemish-free complexion should no longer be considered vanity. Rather, people should see it as a preventive measure for the most common skin disorder affecting some...
Rid Yourself Of Acne With Three Proven Steps
Acne is one skin condition that almost everyone in the world has had at some point in their life. Although acne generally hits hardest during the teenage years, most adults still suffer from acne from time to time. There are hundreds of myths...
The Best Acne Treatments
The best acne treatments may be the ones that help you avoid the acne in the first place. The best acne treatments can be prescribed by your doctor. You will have to decide the best acne treatments for you. One of the best acne treatments has to do...
Why Hydrogenated Oils Are Bad For You
Warning: Do not eat foods that contain partially
hydrogenated and hydrogenated fats. These fats are
found in all kinds of packaged and junk food. Food
manufacturers really don't care about your health
when they add hydrogenated oils to their...
|
|
| |
|
|
|
|
|
|
Acne: FDA Approved Aczone For Acne Treatment
The U.S. Food and Drug Administration (FDA) approved to market
Aczone (dapsone) Gel, 5 per cent for acne vulgaris topical
treatment. But patients who have the enzyme deficiency, G6PD
(Glucose 6-phosphate dehydrogenase), will need to be monitored
with regular blood counts to detect if they are predisposed to
one type of anemia (hemolytic anemia).
Aczone, a trademark of QLT USA Inc., is an aqueous topical gel
which contains 5 per cent dapsone. According to scientific
research, combining dapsone in a Solvent Microparticulate (SMP)
gel enables dapsone to be applied topically and safely. This
product achieved significant per cent reduction in the number of
acne lesions and better success rate on the Global Acne
Assessment Score in two randomized double-blind, vehicle
controlled clinical studies in 3000 acne patients.
Oiliness/peeling, dryness, and erythema were the most common
adverse events reported from controlled clinical trials.
However, there were no significant differences in the adverse
event rates between Aczone Gel and vehicle control treated
patients.
1.4 per cent of about 3500 patients had the enzyme deficiency
-in the Aczone clinical trial program- which is consistent with
the incidence in the general North American
population.
The company QLT will undertake a post-approval Phase IV study in
50 acne patients who have G6PD deficiency and follow them for 6
months, after which QLT expects to submit an application to the
FDA to re-evaluate the Aczone label.
The President and Chief Executive Officer of QLT Inc., Paul
Hastings, stated that "Aczone represents an important clinical
advance in dermatology, has demonstrated safety and efficacy in
over 4,000 patients. We are very pleased with the FDA's decision
and confident in Aczone's potential as a new class of treatment
for acne patients". Article written by Hector Milla, editor of
http://www.acnetreatment
stips.com , a website pointing acne treatment tips
and http://www.acnesoluti
onsproducts.com , visit for reviews and acne solution
products information . Thanks for use this article in your
website or ezine keeping a live link.
About the author:
Hector Milla, editor of many websites in different
topics:Moreover he has a degree in business administration.
http://www.disorderskin.com
|
|
|
|
|
|